Skip to main content
. 2024 Jun 27;52(1):102. doi: 10.1007/s00240-024-01598-9

Table 1.

Baseline characteristics of 32 patients with staghorn stones treated with Flexible ureteroscopy and TFL lithotripsy

Parameter No (%)
Age (mean± SD) 41.7±9.3
Hypertension (yes) 13 (40.6%)
Diabetes Mellitus (yes) 9 (28%)
ASA Score (II, III) 16 (50%)
Body mass index (BMI) (kg/m2) (median, range) 27.6 (19–41)
Stone former (yes) 13 (40.6%)
Previous stone surgery (yes) 6 (18.75%)
Preoperative ureteric stent (yes) 8 (25%)
Cause of preoperative stent
 Tight ureter 6
 Obstructive uropathy / pain 2
Preoperative serum creatinine (mg/dl) (median, range) 0.95 (0.8–1.08)
Preoperative eGFR (ml/min) (median, range) 87 (43–100)
Postoperative eGFR (ml/min) (median, range) 91.5 (49–100)
Preoperative Hb (gm/dl) (mean± SD) 14.4±1.5
Postoperative Hb (gm/dl) (mean± SD) 14.3±1.4
Hb deficit (gm/dl) (median, range) 0.2 (-1.0-1.3)
Laterality
 Right 13 (40.6%)
 Left 19 (59.4%)
Stone location
 Renal pelvis 32 (100%)
 Upper calyx 10 (31.3%)
 Middle calyx 21 (65.6%)
 Lower calyx 28 (87.5%)
Stone Morphology
 Partial staghorn (renal pelvis and 1 calyx) 10 (31.25%)
 Partial staghorn (renal pelvis and 2 calyces) 14 (43.75%)
 Complete staghorn 8 (25%)
Secondary calyceal stones (yes) 6 (18.75%)
Stone width (mm) (median, range) 22.2 (19.2–32.8)
Stone length (mm) (median, range) 20 (12–60)
Stone volume (mm3) (median, range) 7339 (3183–53,838)
Stone density (HU) (mean± SD) 1004 ± 342
Stone density
 < 1000 13 (40.6%)
 ≥ 1000 19 (59.4%)
Chemical composition (available in 23 patients)
 Calcium oxalate 10
 Uric acid 6
 Calcium phosphate 1
 Calcium oxalate + uric acid 5
 Calcium oxalate + Ca phosphate 1